Clinuvel Pharmaceuticals Limited (ASX:CUV)
Share Pricing & News Healthcare

AUD 19.98

0.57 (2.937%)
(As on 2022-08-09 19:55:48 AEDT)
Previous Close Open Close*
19.41 19.6 19.98
Market Cap Dividend Yield (Annualized)
AUD 987.219M 0.08%

Day Range
19.4L 20.18 H
52 WEEK HIGH LOW
13.16L 44.67 H

Chart Price & Information

Last Trade 19.98
Change% 2.9366
52 W H/L 44.670/13.160
EBITDA 31.095M
NPAT After Abnormal Items 24.728M
Equity 98.737M
ROE% 25.04%
Total Liabilities 9.83M
Total Revenue 48.108M
Cash and Cash Equivalents 82.691M

Stock Information

Share price 19.98
Market Cap 987.219M
Price/Gross Cash Flow 76.79
Dividend Yield Excluding Special 0.08%
Ending Shares 49.41M
52-Week Range 44.670-13.160
Gross DPS (AUD) 0.025
Gross Dividend Yield (Annualized) 0.08%
Earnings Yield 2.430
Net Tangible Asset (NTA) 1.99
P/E ratio 41.152
Sector P/E --
EPS 48.40
EV/EBITDA 51.54
Net Profit Margin (%) 51.54%
Gross Cash Flows Per Share 0.39
Net Gearing -82.43%
Sales Per Share 0.94
Book Value Per Share 2.00

Similar Companies

Related Articles

About Company

CLINUVEL PHARMACEUTICALS LIMITED (ASX: CUV) is a global biopharmaceutical that is into development of SCENESSE (its proprietary first-in-class drug, as a photoprotective) to manage a range of UV and light related skin disorders and other products for treating genetic disorders.

Corporate Information


Level 11, 535 Bourke Street, MELBOURNE, VIC, AUSTRALIA, 3000

Phone:61 3 9660 4900

Website:http://www.clinuvel.com

Dividends

Ex-Date Net Dividend Frank Flag Period End Date Type Payable

Event Calendar

Event Type Event Date Event Year
Report (Interim) 2023-02-22 2023
Report (Annual) 2022-10-07 2022
Report (Prelim) 2022-08-26 2022
Report (Prelim) 2022-08-25 2022